Transcatheter aortic valve replacement (TAVR) in the modern era of valvular disease management is considered an attractive alternative to surgery in higher-risk patients with symptomatic aortic stenosis. We report on a case of failed TAVR in a 78-year-old male, complicated by the dislodgment of a CoreValve into the distal ascending aorta after it was successfully implanted. The case was managed surgically by retrieving and re-implanting the dislodged valve as a bailout strategy.
Forouzannia et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: